Case Studies

Question 1

Case Study 1: Eliminating Meningitis A across Africa’s Meningitis Belt

Answer 1

• Disease: Meningitis A
• Targeted Population: People living in the 7 hyper-endemic countries of Africa’s meningitis belt
• Intervention design: Developed, tested, licensed, introduced a meningococcal conjugate vaccine, MenAfriVac, designed to prevent group A meningococcal meningitis
• Actors involved: Gave, USAID, Bill & Melinda Gates Foundation, Dell Foundation
• Why it Worked: Creative partnerships. Technological innovation. Widespread coverage. Increased surveillance. Multi-partner commitment. Program’s vision and structure

Question 2

Case Study 4: Zambia’s National Malaria Control Program

Answer 2

Disease: Malaria

• Targeted Population: People of Zambia
• Intervention design: Put in place a national program to prevent and control malaria using insecticide- treated nets, indoor residual spraying, rapid diagnostic tests and combination therapy drugs
• Actors involved: WHO, Roll Back Malaria Partnership, UNICEF, World Bank, and the United Nations Development Programme, the Global Fund, USAID, MACEPA, President’s Malaria Initiative
• Why it Worked: Committed leadership. Multifaceted, comprehensive program

Question 3

Case Study 22: Peru’s Hand Washing Initative

Answer 3

Disease: Childhood diarrhea and respiratory infection

• Targeted Population: Children under 5 years
• Intervention design:
• Actors involved: WSP of World Bank
• Why it didn’t Work:

Question 4

Case Study 2: Botswana ART Program

Answer 4

Disease: HIV

• Targeted Population: HIV carriers of Botswana
• Intervention design:
• Actors involved: Merck and Bill/Melinda Gates Foundation
• Why it Worked: It had financial support from donors, decentralization of ART distribution

Question 5

Case Study 6: Kenya’s Deworming

Answer 5

Disease: Worm Disease

• Targeted Population: school children
• Intervention design:
• Actors involved: CIEF, END Fund, Deworm the World
• Why it Worked: